Barclays PLC Amphastar Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

A detailed history of Barclays PLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Barclays PLC holds 74,456 shares of AMPH stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,456
Previous 74,456 -0.0%
Holding current value
$3.24 Million
Previous $3.61 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$36.99 - $50.09 $957,227 - $1.3 Million
25,878 Added 53.27%
74,456 $3.61 Million
Q2 2024

Aug 14, 2024
SELL
$38.65 - $43.48 $860,117 - $967,603
-22,254 Reduced 31.42%
48,578 $1.94 Million
Q1 2024

May 15, 2024
BUY
$42.85 - $63.45 $325,231 - $481,585
7,590 Added 12.0%
70,832 $3.11 Million
Q4 2023

Feb 15, 2024
BUY
$44.49 - $62.93 $1.76 Million - $2.48 Million
39,449 Added 165.8%
63,242 $3.91 Million
Q3 2023

Nov 07, 2023
SELL
$45.51 - $65.0 $294,176 - $420,160
-6,464 Reduced 21.36%
23,793 $1.09 Million
Q2 2023

Aug 03, 2023
SELL
$35.77 - $58.38 $395,508 - $645,507
-11,057 Reduced 26.76%
30,257 $1.74 Million
Q1 2023

May 04, 2023
SELL
$27.99 - $37.92 $605,031 - $819,678
-21,616 Reduced 34.35%
41,314 $1.55 Million
Q4 2022

Feb 13, 2023
BUY
$27.93 - $31.27 $207,408 - $232,211
7,426 Added 13.38%
62,930 $1.76 Million
Q3 2022

Nov 03, 2022
SELL
$27.56 - $37.75 $237,401 - $325,178
-8,614 Reduced 13.43%
55,504 $1.56 Million
Q2 2022

Aug 12, 2022
BUY
$29.79 - $42.29 $350,717 - $497,880
11,773 Added 22.49%
64,118 $2.23 Million
Q1 2022

May 16, 2022
SELL
$22.96 - $36.45 $484,111 - $768,548
-21,085 Reduced 28.71%
52,345 $1.88 Million
Q4 2021

Feb 14, 2022
BUY
$18.14 - $23.29 $174,379 - $223,886
9,613 Added 15.06%
73,430 $1.71 Million
Q3 2021

Nov 09, 2021
BUY
$17.83 - $21.49 $323,275 - $389,635
18,131 Added 39.69%
63,817 $1.21 Million
Q2 2021

Aug 13, 2021
SELL
$17.11 - $20.92 $503,564 - $615,696
-29,431 Reduced 39.18%
45,686 $921,000
Q1 2021

May 13, 2021
BUY
$17.21 - $20.65 $38,361 - $46,028
2,229 Added 3.06%
75,117 $1.38 Million
Q4 2020

Feb 11, 2021
BUY
$17.76 - $21.24 $72,975 - $87,275
4,109 Added 5.97%
72,888 $1.47 Million
Q3 2020

Nov 12, 2020
BUY
$17.99 - $22.22 $228,670 - $282,438
12,711 Added 22.67%
68,779 $1.29 Million
Q2 2020

Aug 12, 2020
BUY
$14.25 - $22.46 $182,300 - $287,330
12,793 Added 29.56%
56,068 $1.26 Million
Q1 2020

May 13, 2020
SELL
$12.66 - $20.08 $147,944 - $234,654
-11,686 Reduced 21.26%
43,275 $642,000
Q4 2019

Feb 10, 2020
BUY
$17.07 - $20.64 $299,817 - $362,520
17,564 Added 46.97%
54,961 $1.06 Million
Q3 2019

Nov 14, 2019
SELL
$19.12 - $22.62 $76,556 - $90,570
-4,004 Reduced 9.67%
37,397 $742,000
Q2 2019

Aug 14, 2019
BUY
$18.92 - $22.96 $195,859 - $237,681
10,352 Added 33.34%
41,401 $873,000
Q1 2019

May 15, 2019
BUY
$19.46 - $25.28 $345,084 - $448,290
17,733 Added 133.17%
31,049 $634,000
Q4 2018

Feb 14, 2019
SELL
$17.72 - $22.51 $439,385 - $558,157
-24,796 Reduced 65.06%
13,316 $265,000
Q3 2018

Nov 14, 2018
BUY
$15.39 - $19.38 $305,075 - $384,169
19,823 Added 108.39%
38,112 $733,000
Q2 2018

Aug 14, 2018
BUY
$14.63 - $19.6 $11,104 - $14,876
759 Added 4.33%
18,289 $278,000
Q1 2018

May 15, 2018
BUY
$17.23 - $20.35 $202,383 - $239,031
11,746 Added 203.08%
17,530 $328,000
Q4 2017

Feb 14, 2018
BUY
$17.76 - $19.75 $87,769 - $97,604
4,942 Added 586.94%
5,784 $112,000
Q3 2017

Nov 14, 2017
BUY
$14.73 - $17.99 $12,402 - $15,147
842
842 $15,000

Others Institutions Holding AMPH

# of Institutions
287
Shares Held
35.1M
Call Options Held
74.3K
Put Options Held
22.3K
View Full List

About Amphastar Pharmaceuticals, Inc.

AMPH Quotes by TradingView
  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.14B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email